Azernews.Az

Monday December 22 2025
Azerbaijan finds new path to economic resilience in pharmaceuticals [OPINION]

Azerbaijan finds new path to economic resilience in pharmaceuticals [OPINION]

Azerbaijan’s diversification story is often told through grand infrastructure projects, but its most durable gains may be emerging in less visible industries. It is not dramatic enough to move oil markets or shake currency charts, yet its implications run deeper than a single industry’s balance sheet. The steady expansion of domestic pharmaceutical production signals a broader shift in how the country is positioning itself for a more resilient economic future.

bp launches seismic exploration at Qarabagh field in Azerbaijani Caspian sector

bp launches seismic exploration at Qarabagh field in Azerbaijani Caspian sector

British energy company bp has officially launched seismic exploration works at the “Qarabagh” field located in the Azerbaijani sector of the Caspian Sea, marking an important step toward assessing the field’s development potential, Azernews reports.

Azerbaijan’s lamb imports see sharp growth

Azerbaijan’s lamb imports see sharp growth

The significant growth in imports indicates rising domestic demand and diversification of supply sources, as Azerbaijan continues to strengthen food security and meet consumption needs through international markets.

How diaspora politics in Washington distort justice in South Caucasus [OPINION]

How diaspora politics in Washington distort justice in South Caucasus [OPINION]

There is something strikingly familiar about the latest legislative initiative introduced by Representatives Gus Bilirakis and Frank Pallone. Once again, a pair of United States lawmakers has placed itself at the centre of a deeply polarised foreign conflict, not by promoting balance or legal clarity, but by recycling talking points carefully curated by the Armenian diaspora lobby in Washington.

Samsung Biologics to acquire GSK’s US plant

Samsung Biologics to acquire GSK’s US plant

Samsung Biologics will acquire a drug manufacturing facility in the United States from GlaxoSmithKline (GSK) for $280 million, marking its first production foothold in the U.S. The move aims to enhance supply chain resilience amid rising biopharmaceutical trade barriers and tariff pressures from the United States, Azernews reports, citing Korean media.

Children's Paralympic Games kick off in Sumgayit [PHOTOS]

Children's Paralympic Games kick off in Sumgayit [PHOTOS]

Children's Paralympic Games has taken place at the Sumgayit Paralympic Sports Complex under the Social Services Agency of the Ministry of Labor and Social Protection of Population, Azernews reports.

Latest See more